Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects

Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects

<b>Background/Objectives:</b> Obesity is a chronic, progressive, recurrent disease associated with impaired health, affecting an increasing proportion of the population worldwide. Newer-generation incretin-based therapies (IBTs) (liraglutide, semaglutide, and tirzepatide) have shown grea...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert F. Kushner, Odd Erik Johansen, Krysmaru Araujo Torres, Trà-Mi Phan, Agnieszka Marczewska
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Obesities
Subjects:
adverse events
GLP-1
incretin-mimetic
obesity
weight loss
nutrition
Online Access:https://www.mdpi.com/2673-4168/5/2/29
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items